Diarrhea

• FDA label_change · 2018-12-11
  FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)

  The FDA approved a supplemental application for Imodium Multi-Symptom Relief (loperamide hydrochloride and dimethicone) submitted by Kenvue …

• FDA label_change · 2017-03-28
  FDA Approved: MOTOFEN — Supplemental Application (Legacy Pharma USA Inc.)

  The FDA approved a supplemental application for MOTOFEN (difenoxin and atropine sulfate) submitted by Legacy Pharma USA Inc., resulting in u…

• FDA label_change · 2015-09-01
  FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)

  FDA approved a supplemental application for Imodium Multi-Symptom Relief (loperamide hydrochloride and dimethicone) to expand its labeling f…

• FDA label_change · 2015-08-07
  FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)

  FDA approved a supplemental submission to add Imodium Multi-Symptom Relief (loperamide hydrochloride and dimethicone) to its product line un…

• FDA label_change · 2015-03-18
  FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)

  The FDA approved a supplemental application for Imodium Multi-Symptom Relief (loperamide hydrochloride and dimethicone) submitted by Kenvue …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.